Table 1

Baseline patient and device characteristics

Gender
 Male21 (53.8%)
 Female18 (46.2%)
Age (years)53.8 ± 24.2
Cardiac MRI indication
 Ischaemic cardiomyopathy20 (51.3%)
  Myocardial viability19
  Myocardial perfusion1
 Congenital heart disease13 (33.3%)
  Right ventricle after Fallot surgery6
  Systemic ventricle after Mustard surgery3
  Systemic ventricle in ccTGA patients2
  Heterotaxia syndrome with single atria2
 Evaluation of the right ventricle4 (10.3%)
  Arrhythmogenic right ventricular cardiomyopathy2
  Severe tricuspid regurgitation2
 Other2 (5.1%)
  Pulmonary vein stenosis after AF ablation1
  Cardiac amyloidosis1
Pacing mode
 Pacemaker
  VVI14 (35.9%)
  VDD6 (15.4%)
  DDD11 (28.2%)
 ICD
  VVEV2 (5.1%)
  VVED2 (5.1%)
  DDED4 (10.3%)
Manufacturer
 Medtronic®12 (30.8%)
 Vitatron®4 (10.3%)
 Biotronik®5 (12.8%)
 Sorin®4 (10.3%)
 St. Jude Medical®6 (15.4%)
 Boston Scientific®8 (20.5%)
Gender
 Male21 (53.8%)
 Female18 (46.2%)
Age (years)53.8 ± 24.2
Cardiac MRI indication
 Ischaemic cardiomyopathy20 (51.3%)
  Myocardial viability19
  Myocardial perfusion1
 Congenital heart disease13 (33.3%)
  Right ventricle after Fallot surgery6
  Systemic ventricle after Mustard surgery3
  Systemic ventricle in ccTGA patients2
  Heterotaxia syndrome with single atria2
 Evaluation of the right ventricle4 (10.3%)
  Arrhythmogenic right ventricular cardiomyopathy2
  Severe tricuspid regurgitation2
 Other2 (5.1%)
  Pulmonary vein stenosis after AF ablation1
  Cardiac amyloidosis1
Pacing mode
 Pacemaker
  VVI14 (35.9%)
  VDD6 (15.4%)
  DDD11 (28.2%)
 ICD
  VVEV2 (5.1%)
  VVED2 (5.1%)
  DDED4 (10.3%)
Manufacturer
 Medtronic®12 (30.8%)
 Vitatron®4 (10.3%)
 Biotronik®5 (12.8%)
 Sorin®4 (10.3%)
 St. Jude Medical®6 (15.4%)
 Boston Scientific®8 (20.5%)

MRI, magnetic resonance imaging; ccTGA, congenital corrected transposition of the great arteries; AF, atrial fibrillation; ICD, implantable cardioverter defibrillator.

Table 1

Baseline patient and device characteristics

Gender
 Male21 (53.8%)
 Female18 (46.2%)
Age (years)53.8 ± 24.2
Cardiac MRI indication
 Ischaemic cardiomyopathy20 (51.3%)
  Myocardial viability19
  Myocardial perfusion1
 Congenital heart disease13 (33.3%)
  Right ventricle after Fallot surgery6
  Systemic ventricle after Mustard surgery3
  Systemic ventricle in ccTGA patients2
  Heterotaxia syndrome with single atria2
 Evaluation of the right ventricle4 (10.3%)
  Arrhythmogenic right ventricular cardiomyopathy2
  Severe tricuspid regurgitation2
 Other2 (5.1%)
  Pulmonary vein stenosis after AF ablation1
  Cardiac amyloidosis1
Pacing mode
 Pacemaker
  VVI14 (35.9%)
  VDD6 (15.4%)
  DDD11 (28.2%)
 ICD
  VVEV2 (5.1%)
  VVED2 (5.1%)
  DDED4 (10.3%)
Manufacturer
 Medtronic®12 (30.8%)
 Vitatron®4 (10.3%)
 Biotronik®5 (12.8%)
 Sorin®4 (10.3%)
 St. Jude Medical®6 (15.4%)
 Boston Scientific®8 (20.5%)
Gender
 Male21 (53.8%)
 Female18 (46.2%)
Age (years)53.8 ± 24.2
Cardiac MRI indication
 Ischaemic cardiomyopathy20 (51.3%)
  Myocardial viability19
  Myocardial perfusion1
 Congenital heart disease13 (33.3%)
  Right ventricle after Fallot surgery6
  Systemic ventricle after Mustard surgery3
  Systemic ventricle in ccTGA patients2
  Heterotaxia syndrome with single atria2
 Evaluation of the right ventricle4 (10.3%)
  Arrhythmogenic right ventricular cardiomyopathy2
  Severe tricuspid regurgitation2
 Other2 (5.1%)
  Pulmonary vein stenosis after AF ablation1
  Cardiac amyloidosis1
Pacing mode
 Pacemaker
  VVI14 (35.9%)
  VDD6 (15.4%)
  DDD11 (28.2%)
 ICD
  VVEV2 (5.1%)
  VVED2 (5.1%)
  DDED4 (10.3%)
Manufacturer
 Medtronic®12 (30.8%)
 Vitatron®4 (10.3%)
 Biotronik®5 (12.8%)
 Sorin®4 (10.3%)
 St. Jude Medical®6 (15.4%)
 Boston Scientific®8 (20.5%)

MRI, magnetic resonance imaging; ccTGA, congenital corrected transposition of the great arteries; AF, atrial fibrillation; ICD, implantable cardioverter defibrillator.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close